ANDRÉS JESÚS
MUÑOZ MARTÍN

Profesor asociado

Foto de ANDRÉS JESÚS

Foto de David Geffen School of Medicine at UCLA

David Geffen School of Medicine at UCLA

Los Ángeles, Estados Unidos

Publications in collaboration with researchers from David Geffen School of Medicine at UCLA (3)

2023

Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial
The Lancet, Vol. 401, Núm. 10391, pp. 1853-1865

2021

Randomized Phase III Study of FOLFOX Alone or With Pegilodecakin as Second-Line Therapy in Patients With Metastatic Pancreatic Cancer That Progressed After Gemcitabine (SEQUOIA)
Journal of Clinical Oncology, Vol. 39, Núm. 10, pp. 1108-1118

2020

Meta-analysis examining overall survival in patients with pancreatic cancer treated with second-line 5-fluorouracil and oxaliplatin-based therapy after failing first-line gemcitabine-containing therapy: effect of performance status and comparison with other regimens
BMC Cancer, Vol. 20, Núm. 1